These 4 Stocks Saw Trading Price Swings This Past Week Post Earnings

POZEN, Inc. (NASDAQ:POZN) had a loss and beat Wall Street’s expectations, AND beat the revenue expectation. Adjusted Earnings Per Share increased to $-0.13 in the quarter versus EPS of $-0.17 in the year-earlier quarter. Revenue Decreased 3.95% to $1.7 million from the year-earlier quarter.

POZEN, Inc. reported adjusted EPS loss of $0.13 per share. By that measure, the company beat the mean analyst estimate of $-0.20. It beat the average revenue estimate of $1.3 million.

POZN 20130811

Techne Corp. (NASDAQ:TECH) delivered a profit and missed Wall Street’s expectations, AND came up short on beating the revenue expectation. Adjusted Earnings Per Share increased 2.5% to $0.82 in the quarter versus EPS of $0.80 in the year-earlier quarter. Revenue Rose 1.04% to $79.5 million from the year-earlier quarter.

Techne Corp. reported adjusted EPS income of $0.82 per share. By that measure, the company missed the mean analyst estimate of $0.83. It missed the average revenue estimate of $79.71 million.

TECH 20130811

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) delivered a profit and beat Wall Street’s expectations, BUT came up short on beating the revenue expectation. Adjusted Earnings Per Share increased 147.14% to $1.73 in the quarter versus EPS of $0.70 in the year-earlier quarter. Revenue Rose 50.33% to $457.6 million from the year-earlier quarter.

Regeneron Pharmaceuticals, Inc. reported adjusted EPS income of $1.73 per share. By that measure, the company beat the mean analyst estimate of $0.88. It missed the average revenue estimate of $473.23 million.

REGN 20130811

Endo Health Solutions (NASDAQ:ENDP) delivered a profit and beat Wall Street’s expectations, AND beat the revenue expectation. Adjusted Earnings Per Share increased 11.81% to $1.42 in the quarter versus EPS of $1.27 in the year-earlier quarter. Revenue Decreased 2.37% to $766.6 million from the year-earlier quarter.

Endo Health Solutions reported adjusted EPS income of $1.42 per share. By that measure, the company beat the mean analyst estimate of $1.15. It beat the average revenue estimate of $721.01 million.

ENDP 20130811

Stocks with improving earnings metrics are worthy of your extra attention. In fact, “E = Earnings Are Increasing Quarter-Over-Quarter” is a core component of our CHEAT SHEET investing framework for this very reason. Don’t waste another minute – click here and get our CHEAT SHEET stock picks now.

More Articles About:   , , ,  

More from The Cheat Sheet